COVID-19: Are our methods up to the task?

ISPOR and the Innovation and Value Initiative (IVI) are collaborating—with help from an expert advisory committee—to define a series of dialogues that highlight key challenges confronting HEOR methodologists, patients, clinicians, and policy-makers during the COVID-19 pandemic. The webinar series will explore multiple viewpoints and focus on potential pathways for solutions in international and U.S.-focused health technology assessment and value assessment (VA/HTA).

The second installment of this webinar series will talk about the methods, assumptions, and inputs to VA/HTA are an evolving debate in the U.S., as we seek to balance questions of population health-driven resource allocation with the unique needs of health system, employer, payer, and societal decision-making and the emerging science of patient heterogeneity and precision medicine. COVID-19 amplifies the challenge to identify and prioritize the methods that should be developed and applied across interventions, including diagnostics, treatments, and vaccines.

Through participation in moderated one-hour webinar discussions, attendees will:

  • Discuss the key methodological challenges in VA/HTA for health technologies to treat or prevent COVID-19
  • Evaluate the key-value elements that should be considered, and their interactions in VA/HTA
  • Identify and prioritize the readiness of specific methods to address challenges in VA/HTA for COVID-19 
  • Identify specific steps to engage various stakeholders to collaborate in tackling these challenges

This series is sponsored by ISPOR and Innovation and Value Initiative

Final ISPOR_4.1-01 (1)
IVI_Logo_FINAL


Watch Past Webinars On Demand:

July 29, 2020 - the first installment of this webinar series is "How Should The COVID-19 Pandemic Challenge Conventional Wisdom About VA/HTA?"

Speakers

Moderator:

Lou Garrison, PhD
Professor Emeritus, Department of Pharmacy
Assistant Director, Pharmaceutical Outcomes Research & Policy Program
Adjunct Professor and Co-Director of Global Medicines Program, UW Department of Global Health
Adjunct Professor, UW Department of Health Services
University of Washington, School of Pharmacy
Seattle, WA

Presenters:

Anirban Basu, PhD
Stergachis Family Endowed Director
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute
Professor of Health Economics
Departments of Pharmacy, Health Services, and Economics University of Washington, Seattle
University of Washington
Seattle, WA

Charles Phelps, PhD
University Professor and Provost Emeritus of the University of Rochester
University of Rochester
Rochester, NY, USA

Dan Ollendorf, PhD
Director, Value Measurement & Global Health Initiatives
Center for the Evaluation of Value and Risk in Health
Institute for Clinical Research and Health Policy Studies
Assistant Professor of Medicine
Tuffts Medical Center
Boston, MA, USA

Susan Griffin, PhD
Senior Research Fellow, Center for Health Economics
University of York
Heslington, York, UK

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×